September 21, 2026 at 12:04 PM UTC
Cue Biopharma, Inc. issues Regulation FD disclosure
Cue Biopharma, Inc. filed an 8-K covering a Regulation FD disclosure and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 21, 2026 at 12:00 PM UTC
Open official source